Press release -

Center for Translational Research AB establishes a new regulatory company

Center for Translational Research AB (CTR), holding company for CTC Clinical Trial Consultants AB, starts a new regulatory consulting company with focus on pharmaceuticals and medical device. Marie Gårdmark has been assigned as CEO for the new corporation.

The company will be further strengthened with senior regulatory competence within the areas of medical device and chemistry, manufacturing and control (CMC).

Marie Gårdmark has long regulatory experience as Head of Department and Director of Licensing at the Medical Products Agency and has had several regulatory strategic roles within the pharmaceutical industry.

”We are very happy that Marie Gårdmark with so much experience and knowledge has accepted the role as CEO for this new company. The company will constitute a qualified and important actor in the regulatory area and will assist other companies and scientists to navigate in a complex and rapidly changing regulatory landscape”, says Bengt Dahlström, Chairman of the Board, CTR.

Topics

  • Corporate Information

Contacts

  • Bengt Dahlström

    Chairman of the Board Center for Translational Research AB +4670-3108587

  • Mats Lindquist

    CEO Center for Translational Research AB +4673-3319100

Related content

  • ​Increased focus on phase II trials

    The corporate group is growing when CTC’s holding company Center for Translational Research Sweden (CTR) is staring an additional company, ClinSmart Sweden. The company will have a strong focus on digital solutions and will, together with CTC, conduct clinical trials in phase II and forward.

  • CTR acquires preclinical toxicology company

    Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR.

Enter your email address to follow CTC Clinical Trial Consultants AB

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow CTC Clinical Trial Consultants AB.

Okay